Kenneth Widder

Luminous Medical is developing an Automated Blood Glucose Monitor (ABGM) that addresses the rapidly growing clinical demand for better, safer glycemic control in the intensive care unit (ICU), Operating Room (OR) and Intermediate Care Units. Compelling clinical evidence has demonstrated significant morbidity and mortality benefits from normalizing glucose levels in hyperglycemic patients. As a result, clinicians have rapidly adopted glycemic control procedures but struggle with time consuming and inadequate manual glucose monitoring methods.

Meritage Pharma, Inc. develops prescription products for the treatment of gastrointestinal and atopic diseases. The company was founded by Cam L. Garner, Elaine M. Phillips and Adam K. Simpson in March 2008 and is headquartered in San Diego, CA.

Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL.

Converge Medical, Inc. develops novel medical devices for cardiac surgery. The company focuses on develops technology that facilitates less invasive surgical procedures such as coronary artery bypass graft surgery (CABG). The company is located in Sunnyvale, CA.

Windamere Venture Partners LLC (Windamere Venture Partners) is an independent venture capital firm founded in 1999 by Scott L. Glenn. The firm is headquartered in San Diego.

Part of Bausch Health Cos., Inc., Sytera, Inc. is a biopharmaceutical company that provides biopharmaceutical services and products. The company is based in La Jolla, CA. The company was founded by Jay B. Lichter, Kenneth J. Widder, Nathan L. Mata. Sytera was acquired by Sirion Therapeutics, Inc. on August 16, 2006 for $250 million.

eStudySite, Inc. engages in the provision of clinical trials research services. It offers acne, weight loss, skin infection, diabetes, bacteremia, psoriasis, shingles, and diabetic foot infection studies. The company was founded by William D. O'Riordan and Paul Manos in 1999 and is headquartered in La Mesa, CA.

FeRx Inc. develops, manufactures, and distributes magnetic targeted carrier technology for the treatment of cancer. Its technology is used in therapeutic areas and provides technology platform for delivery of small molecules, radionuclides, biologics and genetic vectors. The company was registered in 1997 and is headquartered in San Diego, CA.

Femta Pharmaceuticals, Inc. develops antibody therapeutics. The company was founded in June 2008 and is headquartered in San Diego, CA.

The San Diego Museum of Art operates as an arts museum. The private company is based in San Diego, CA and has subsidiaries in the United States. The company was founded in 1922 by Jennifer Personette. Roxana Velasquez has been the CEO of the company since 2010.

OrphoMed, Inc. develops and manufactures pharmaceutical products. The company was founded Pankaj Jay Pasricha and Frank Steinberg and is headquartered in Mill Valley, CA.

Sydnexis, Inc. engages in the production of ophthalmic pharmaceutical products. The company was founded by Gregory Isaac Ostrow in 2014 and is headquartered in San Diego, CA.